Medical Condition News

RSS

3D protein structure reveals new drug targets for cancer, neurodegenerative diseases

Protein Kinase C (PKC) is a family of enzymes that controls the activity of other proteins in a cell by attaching chemical tags. That simple act helps determine cell survival or death.

14 Aug 2015

Rice and UTHealth scientists awarded $1.02 million NSF grant to examine how the brain processes language

The National Science Foundation has awarded a $1.02 million grant to scientists at Rice University and the University of Texas Health Science Center at Houston Medical School to study how the brain processes language. The joint research may one day help people who lose the ability to communicate.

14 Aug 2015

Organ transplant recipients more likely to develop melanoma

Organ transplant recipients are twice as likely to develop melanoma as people who do not undergo a transplant, and three times more likely to die of the dangerous skin cancer, suggests new research led by a Johns Hopkins Bloomberg School of Public Health student.

14 Aug 2015

USC kidney researcher named recipient of ASN-AHA Young Investigator Award

Keck School of Medicine of the University of Southern California kidney researcher Janos Peti-Peterdi is the 2015 recipient of the ASN-AHA Young Investigator Award.

14 Aug 2015

TSRI-led team devises selection-based, protein-engineering method to work on obesity therapy

Some proteins exist so fleetingly in the bloodstream that they can’t be given effectively as therapies. However, building them into larger proteins, such as antibodies, can make them persist long enough to be useful. Now a team led by scientists at The Scripps Research Institute has devised an improved method for accomplishing this protein-engineering feat.

14 Aug 2015

Low birth weight, preterm birth increase schizophrenia risk in individuals with 22q11.2 deletion syndrome

Low birth weight and preterm birth appear to increase the risk of schizophrenia among individuals with a genetic condition called the 22q11.2 deletion syndrome, a new study from the Centre for Addiction and Mental Health (CAMH) shows.

14 Aug 2015

New study uses big data analytical methods to reveal 'social character' of genes

A new study at the University of Haifa has used "big data" analytical methods to reveal the "social character" of genes - a phenomenon in certain diseases whereby genes operate jointly rather than independently.

14 Aug 2015

Researchers use advanced photodynamic therapy to combat ovarian cancer in laboratory animals

Researchers at Oregon State University have made a significant advance in the use of photodynamic therapy to combat ovarian cancer in laboratory animals, using a combination of techniques that achieved complete cancer cell elimination with no regrowth of tumors.

14 Aug 2015

Researchers develop new way to personalize treatments for aggressive bladder cancer

Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer.

14 Aug 2015

Rush researchers explore new stem cell therapy to treat spinal cord injuries

Researchers at Rush University Medical Center are exploring a new therapy using stem cells to treat spinal cord injuries within the first 14 to 30 days of injury. Rush is only the second center in the country currently studying this new approach.

14 Aug 2015

Merck, MD Anderson form strategic clinical research collaboration to evaluate anti-PD-1 therapy

Merck and The University of Texas MD Anderson Cancer Center announced a strategic clinical research collaboration to evaluate Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel anti-tumor medicines.

14 Aug 2015

Neurocrine completes enrollment in Phase III clinical trial of NBI-98854 in tardive dyskinesia patients

Neurocrine Biosciences, Inc. announced today that it has recently completed subject randomization of the Phase III clinical trial (Kinect 3 Study) of its proprietary Vesicular Mono-Amine Transporter 2 (VMAT2) compound NBI-98854 in tardive dyskinesia patients.

13 Aug 2015

New endoscopic system differentiates between malignant and benign tumors in gastrointestinal tract

Cancer or no cancer? This question can usually only be answered after a days-long wait for a histological examination. With the use of a mass spectrometric technique, the answer may soon be available in real time.

13 Aug 2015

Charlotte charity Taylor's Tale inspires new law to create treatments for rare diseases, spur growth in NC

Charlotte charity Taylor's Tale helped inspire a law designed to stimulate the creation of new treatments for rare diseases and spur economic development in North Carolina.

13 Aug 2015

Combination of chemotherapy and immune-blocking drug could prevent cancer recurrence

Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people, according to research published today in Cancer Research.

13 Aug 2015

ImmunoCellular signs agreement with FDA for phase 3 registrational trial of cancer immunotherapy ICT-107

ImmunoCellular Therapeutics, Ltd. announced today that it has reached agreement with the US Food and Drug Administration on a Special Protocol Assessment (SPA) for the phase 3 registrational trial of its cancer immunotherapy ICT-107 to treat patients with newly diagnosed glioblastoma.

13 Aug 2015

Inhibikase Therapeutics launches observational clinical study in patients who survived PML

Inhibikase Therapeutics, Inc. announces the launch of an observational clinical study in patients who contracted Progressive Multifocal Leukoencephalopathy (PML), the rare and often fatal brain infection that arises as an unintended side effect of some medications used for treatment of Multiple Sclerosis, Crohn's disease, Ulcerative Colitis and certain cancers of the blood and lymph.

13 Aug 2015

BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.

13 Aug 2015

ADDF establishes Goodes Prize to recognize scientists in Alzheimer's drug discovery research

Thanks to the generosity of former Warner-Lambert CEO and Chairman Melvin R. Goodes and his family, the Alzheimer's Drug Discovery Foundation has established the only prize specifically recognizing scientists in Alzheimer's drug discovery research. Mr. Goodes—who has been open about his own Alzheimer's diagnosis—is an honorary member of the ADDF's Board of Governors.

13 Aug 2015

Scientists reveal how non-allergenic pollen mediators can increase allergic reactions

Scientists at Helmholtz Zentrum München and TU München discovered a new mechanism how non-allergenic pollen mediators can enhance allergic reactions. Especially the so-called B cells play a critical role in this process. The results were recently published in the Journal 'Allergy' and might lead to new approaches for therapies.

13 Aug 2015

Medical Condition News

3D protein structure reveals new drug targets for cancer, neurodegenerative diseases

Rice and UTHealth scientists awarded $1.02 million NSF grant to examine how the brain processes language

Organ transplant recipients more likely to develop melanoma

USC kidney researcher named recipient of ASN-AHA Young Investigator Award

TSRI-led team devises selection-based, protein-engineering method to work on obesity therapy

Low birth weight, preterm birth increase schizophrenia risk in individuals with 22q11.2 deletion syndrome

New study uses big data analytical methods to reveal 'social character' of genes

Researchers use advanced photodynamic therapy to combat ovarian cancer in laboratory animals

Researchers develop new way to personalize treatments for aggressive bladder cancer

Rush researchers explore new stem cell therapy to treat spinal cord injuries

Merck, MD Anderson form strategic clinical research collaboration to evaluate anti-PD-1 therapy

Neurocrine completes enrollment in Phase III clinical trial of NBI-98854 in tardive dyskinesia patients

New endoscopic system differentiates between malignant and benign tumors in gastrointestinal tract

Charlotte charity Taylor's Tale inspires new law to create treatments for rare diseases, spur growth in NC

Combination of chemotherapy and immune-blocking drug could prevent cancer recurrence

ImmunoCellular signs agreement with FDA for phase 3 registrational trial of cancer immunotherapy ICT-107

Inhibikase Therapeutics launches observational clinical study in patients who survived PML

BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

ADDF establishes Goodes Prize to recognize scientists in Alzheimer's drug discovery research

Scientists reveal how non-allergenic pollen mediators can increase allergic reactions

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Latest News